Clinical Trial Update: Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta

View source ↗

Summary

This clinical trial evaluates cell-free fetal DNA in maternal plasma as a biomarker for morbidly adherent placenta and related placenta accreta spectrum conditi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbidly Adherent Placenta
• Placenta Accreta
• Placenta Increta
• Placenta Percreta

Snippet

Sponsor: University Hospital, Angers | Conditions: Morbidly Adherent Placenta, Placenta Accreta | Status: UNKNOWN